Dietary DHA: Time course of tissue uptake and effects on cytokine secretion in mice

British Journal of Nutrition

Volumn 104, Issue 9, 2010, Pages 1304-1312

  Lefils, Jennifer ^a   Géloën, Alain ^a   Vidal, Hubert ^a   Lagarde, Michel ^a   Bernoud Hubac, Nathalie ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Adiponectin; Docosahexaenoic acid; Leptin; Mice

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ARACHIDONIC ACID; CYTOKINE; DOCOSAHEXAENOIC ACID; LEPTIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; FAT INTAKE; FATTY ACID TRANSPORT; HEART; HORMONE BLOOD LEVEL; LIVER; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; HEART MUSCLE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; SECRETION; TIME; TISSUE DISTRIBUTION; WHITE ADIPOSE TISSUE;

MUS;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; ARACHIDONIC ACID; CYTOKINES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; LEPTIN; LIVER; MALE; MICE; MICE, INBRED ICR; MYOCARDIUM; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 78149481036     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510002102     Document Type: Article

References (58)

1. Schmidt EB, Skou HA, Christensen JH, et al. (2000) N-3 fatty acids from fish and coronary artery disease: Implications for public health. Public Health Nutr 3, 91-98.
2. Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71, 171S-175S.
3. Holub BJ (2002) Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. CMAJ 166, 608-615.
4. Flachs P, Rossmeisl M, Bryhn M, et al. (2009) Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) 116, 1-16.
5. González-Périz A, Horrillo R, Ferré N, et al. (2009) Obesityinduced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J 23, 1946-1957.
6. al-Shurbaji A, Larsson-Backström C, Berglund L, et al. (1991) Effect of n-3 fatty acids on the key enzymes involved in cholesterol and triglyceride turnover in rat liver. Lipids 26, 385-389.
7. Flachs P, Horakova O, Brauner P, et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48, 2365-2375.
8. Jump DB (2004) Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41, 41-78.
9. Díez JJ & Iglesias P (2003) The role of the novel adipocytederived hormone adiponectin in human disease. Eur J Endocrinol 148, 293-300.
10. Arita Y, Kihara S, Ouchi N, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83.
11. Nawrocki AR, Rajala MW, Tomas E, et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281, 2654-2660.
12. Shklyaev S, Aslanidi G, Tennant M, et al. (2003) Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 100, 14217-14222.
13. Hotta K, Funahashi T, Arita Y, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599.
14. Ryan AS, Berman DM, Nicklas BJ, et al. (2003) Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26, 2383-2388.
15. Bruun JM, Lihn AS, Verdich C, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285, E527-E533.
16. Flachs P, Mohamed-Ali V, Horakova O, et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49, 394-397.
17. Krebs JD, Browning LM, McLean NK, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 1535-1544.
18. Ahima RS & Flier JS (2000) Leptin. Annu Rev Physiol 62, 413-437.
19. Sader S, Nian M & Liu P (2003) Leptin: A novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation 108, 644-646.
20. Janik JE, Curti BD, Considine RV, et al. (1997) Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 82, 3084-3086.
21. Grunfeld C, Zhao C, Fuller J, et al. (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97, 2152-2157.
22. Francis J, MohanKumar PS, MohanKumar SM, et al. (1999) Systemic administration of lipopolysaccharide increases plasma leptin levels: Blockade by soluble interleukin-1 receptor. Endocrine 10, 291-295.
23. Neschen S, Morino K, Rossbacher JC, et al. (2006) Fish oil regulates adiponectin secretion by a peroxisome proliferatoractivated receptor-gamma- dependent mechanism in mice. Diabetes 55, 924-928.
24. Vemuri M, Kelley DS, Mackey BE, et al. (2007) Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)- induced insulin resistance in mice. Metab Syndr Relat Disord 5, 315-322.
25. Ouchi N, Kihara S, Arita Y, et al. (1999) Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
26. Von Schacky C & Weber PC (1985) Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. Clin Invest 76, 2446-2450.
27. Brossard N, Croset M, Pachiaudi C, et al. (1996) Retroconversion and metabolism of [13C]22 : 6n-3 in humans and rats after intake of a single dose of [13C]22 : 6n-3-triacylglycerols. Am J Clin Nutr 64, 577-586.
28. Stark KD & Holub BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 79, 765-773.
29. Lands WE, Libelt B, Morris A, et al. (1992) Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1180, 147-162.
30. Sperling RI, Benincaso AI, Knoell CT, et al. (1993) Dietary v-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91, 651-660.
31. Mebarek S, Ermak N, Benzaria A, et al. (2009) Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis. Br J Nutr 101, 852-858.
32. Holte LL, Separovic F & Gawrisch K (1996) Nuclear magnetic resonance investigation of hydrocarbon chain packing in bilayers of polyunsaturated phospholipids. Lipids 31, S199-S203.
33. Stubbs CD & Smith AD (1984) The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779, 89-137.
34. Hashimoto M, Hossain S & Shido O (2006) Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol- induced decreases in platelet membrane fluidity. Mol Cell Biochem. 293, 1-8.
35. Siener R, Alteheld B, Terjung B, et al. (2010) Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases. Eur J Clin Nutr 64, 410-418.
36. Yehuda S, Rabinovitz S & Mostofsky DI (1999) Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 56, 565-570.
37. James MJ, Gibson RA & Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 1 Suppl., 343S-348S.
38. Serhan CN, Gotlinger K, Hong S, et al. (2004) Resolvins, docosatrienes, and neuroprotectins, novel omegα-3-derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 73, 155-172.
39. Charnock JS, Abeywardena MY, Poletti VM, et al. (1992) Differences in fatty acid composition of various tissues of the marmoset monkey (Callithrix jacchus) after different lipid supplemented diets. Comp Biochem Physiol Comp Physiol 101, 387-393.
40. Andersen LF, Solvoll K, Johansson LR, et al. (1999) Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 150, 75-87.
41. Geerling BJ, v Houwelingen AC, Badart-Smook A, et al. (1999) Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol 94, 410-417.
42. Kopecky J, Rossmeisl M, Flachs P, et al. (2009) n-3 PUFA: Bioavailability and modulation of adipose tissue function. Proc Nutr Soc. 68, 361-369.
43. Einstein FH, Atzmon G, Yang XM, et al. (2005) Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54, 672-678.
44. Bueno AA, Oyama LM, de Oliveira C, et al. (2008) Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflugers Arch. 455, 701-709.
45. Mori T, Kondo H, Hase T, et al. (2007) Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr 137, 2629-2634.
46. Ruzickova J, Rossmeisl M, Prazak T, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 1177-1185.
47. Kunesová M, Braunerová R, Hlavatý P, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55, 63-72.
48. Couet C, Delarue J, Ritz P, et al. (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 21, 637-643.
49. Xu J, Nakamura MT, Cho HP, et al. (1999) Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J Biol Chem 274, 23577-23583.
50. Yahagi N, Shimano H, Hasty AH, et al. (1999) Crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem 274, 35840-35844.
51. Raclot T, Groscolas R, Langin D, et al. (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38, 1963-1972.
52. Azain MJ (2004) Role of fatty acids in adipocyte growth and development. J Anim Sci 82, 916-924.
53. Lapillonne A, Clarke SD & Heird WC (2004) Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care 7, 151-156.
54. Takahashi Y & Ide T (1999) Effect of dietary fats differing in degree of unsaturation on gene expression in rat adipose tissue. Ann Nutr Metab 43, 86-97.
55. Reddy JK & Mannaerts GP (1994) Peroxisomal lipid metabolism. Annu Rev Nutr 14, 343-370.
56. Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, et al. (2002) Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem 277, 9562-9569.
57. Yang WS, Lee WJ, Funahashi T, et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86, 3815-3819.
58. Bruun JM, Lihn AS, Verdich C, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285, E527-E533.